Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society

J Clin Lipidol. 2018 Nov-Dec;12(6):1482-1492.e3. doi: 10.1016/j.jacl.2018.07.013. Epub 2018 Aug 1.

Abstract

Background: Familial chylomicronemia syndrome (FCS) is an extremely rare lipoprotein disorder caused by mutations in at least 5 genes of the lipoprotein lipase (LPL) complex.

Objective: This work shows the molecular analysis of patients diagnosed with FCS, who attended the Spanish Arteriosclerosis Society lipid units and were included in the National Dyslipidemia Registry.

Methods: Among the 238 patients registered with severe hypertriglyceridemia (fasting triglycerides >1000 mg/dL), 26 were diagnosed with FCS as they had confirmed postheparin plasma LPL activity deficiency and/or homozygosity for loss-of-function mutations in LPL, GPIHBP1, APOC2, LMF1, or Apolipoprotein A5 (APOA5).

Results: Among the 26 FCS cases, 23 had mutations in the homozygous state: 19 in LPL and 4 in the GPIHBP1 gene. The molecular analysis revealed 3 novel mutations: 2 in LPL, in 2 unrelated patients (c.312delA; p.Asp105Thrfs*66 and c.629A>G; p.His210Arg), and 1 in GPHIBP1 in a third patient (c.502delC; p.Leu168Serfs*83). These 3 patients had confirmed lack of LPL activity. Three additional patients with confirmed LPL activity deficiency were heterozygous carriers of mutations in the genes analyzed. Among these, we found 2 novel mutations in APOA5 (c.50-1G>A and c.326_327insC; p.Tyr110Leufs*158).

Conclusion: We have identified 5 novel pathogenic mutations: 2 in LPL, 1 in GPIHBP1, and 2 in the APOA5 gene. The genetic defaults accounting for the LPL activity deficiency of 23 of them have been clearly identified and 3 patients, who harbored mutations in heterozygosity, were diagnosed based on LPL activity deficiency, which raises the question of the involvement of new genes in the manifestation of FCS.

Keywords: Candidate genes; Causative mutation; Familial chylomicronemia syndrome; LPL activity; LPL mass.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atherosclerosis*
  • Female
  • Humans
  • Hyperlipoproteinemia Type I / epidemiology
  • Hyperlipoproteinemia Type I / genetics*
  • Hyperlipoproteinemia Type I / metabolism*
  • Lipoprotein Lipase / genetics
  • Lipoprotein Lipase / metabolism
  • Male
  • Middle Aged
  • Mutation
  • Registries / statistics & numerical data*
  • Societies, Medical*
  • Spain
  • Triglycerides / blood

Substances

  • Triglycerides
  • Lipoprotein Lipase

Supplementary concepts

  • Familial hyperchylomicronemia syndrome